focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,106.00
Bid: 1,107.50
Ask: 1,108.50
Change: 21.50 (1.98%)
Spread: 1.00 (0.09%)
Open: 1,080.00
High: 1,109.00
Low: 1,076.00
Prev. Close: 1,084.50
SGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Jan 2021 07:00

RNS Number : 3848M
Sage Group PLC
21 January 2021
 

Trading update for the three months ended 31 December 2020

The Sage Group plc (the "Group") is today issuing its trading update for the three months ended 31 December 2020.

Financial performance

Organic1 Revenue Mix

Q1 FY21

Q1 FY20

Growth

£m

£m

£m

%

 

 

 

 

 

 

Revenue by Category

 

 

 

 

Recurring Revenue

£408m

£390m

+£18m

+4.7%

Other Revenue (SSRS2 & Processing)

£39m

£51m

-£12m

-24.0%

Organic Total Revenue

£447m

£441m

+£6m

+1.4%

 

 

 

 

 

 

Portfolio View of Recurring Revenue

 

 

 

 

Future Sage Business Cloud opportunity

£366m

£345m

+£21m

+6.2%

Non-Sage Business Cloud

£42m

£45m

-£3m

-7.2%

Recurring Revenue

£408m

£390m

+£18m

+4.7%

 

 

 

 

 

 

 

Sage performed in line with expectations in the first quarter, against strong comparators, driven by successful strategic execution.

Recurring revenue increased by 4.7% to £408m, supported by software subscription growth of 11.3% to £303m (Q1 20: £272m). As a result, subscription penetration increased to 68% (FY20: 65%).

Regionally, North America achieved growth in recurring revenue of 6.4% to £160m (Q1 20: £150m) driven principally by a good performance from Sage Intacct. In Northern Europe recurring revenue increased by 3.3% to £96m (Q1 20: £93m), reflecting mainly momentum in cloud connected, together with growth in cloud native solutions. Performance in other regions was largely in line with expectations.

In terms of the portfolio view of recurring revenue, the Future Sage Business Cloud Opportunity (products within, or to be migrated to, Sage Business Cloud) grew by 6.2% to £366m. This was underpinned by strong growth in cloud native revenue of 26.7% to £63m (Q1 20: £50m), primarily through new customer acquisition, and further growth in cloud connected. Sage Business Cloud penetration increased to 64% (FY20: 61%).

In line with our plans to drive further growth in recurring revenue, we are progressively increasing investment in product development and sales and marketing during FY21, with a particular focus on cloud native solutions. As previously indicated, we may flex the level of this investment during the course of the year, in response to trading conditions.

Other revenue (SSRS and processing) decreased by 24.0% to £39m, a similar rate of decline to that seen in FY20. This reduction is in line with Sage's strategy to transition away from licence sales and professional services revenue, and to increase the Group's focus on subscription revenue.

Total Group revenue increased by 1.4% to £447m.

In line with our strategy to create a simpler and more focused business, Sage announced in December that it has agreed to sell Sage Poland to Mid Europa Partners for £66m, and Sage's business in Asia and Australia (excluding global products) to The Access Group for £95m. These businesses were classified as held for sale and excluded from Sage's organic numbers at the FY20 year end.

1 All numbers throughout this document are organic. Organic results exclude contributions from assets held for sale. Full definitions are available in the FY20 results announcement

2 Software and software-related services

 

Financial position

The Group's balance sheet as at 31 December 2020 remains strong, with cash and available liquidity of £1.2 billion, and net debt of £129m (£151m as at 30 September 2020).

Jonathan Howell, Chief Financial Officer, commented:

"We have continued to deliver against our strategy in the first quarter, growing recurring revenue in line with our plan for the year, supported by good demand for Sage Business Cloud solutions. Accordingly, we reiterate our guidance for the full year, as set out in our FY20 results announcement. While the pandemic increases uncertainty in the near term, we continue to expect that our investment in Sage Business Cloud will drive the growth and long-term success of Sage."

Foreign exchange

Sterling strengthened in the quarter against the US dollar and other international currencies, and weakened against the Euro, leading to a broadly neutral exchange rate impact at the Group level.

Analyst and investor conference call

Jonathan Howell will host a conference call at 8:30am GMT today, which will be webcast via a link on Sage's investor relations website, at www.sage.com/investors. The call may also be accessed using the dial-in number 0800 279 6619 (United Kingdom) or +44 (0) 207 192 8338 (International) and pin code 4389661. A replay of the call will also be available for one week after the event on 0844 571 8951 (United Kingdom) or +44 (0) 3333 009 785 (International), pin code 4389661.

Enquiries

The Sage Group plc +44 (0) 7900 046714

Jonathan Howell, Chief Financial Officer

James Sandford, Investor Relations

Amy Lawson, Media

FTI Consulting +44 (0) 20 3727 1000

Charles Palmer

Dwight Burden

 

About Sage

Sage (FTSE: SGE) is the global market leader for technology that provides small and medium businesses with the visibility, flexibility and efficiency to manage finances, operations and people. With our partners, Sage is trusted by millions of customers worldwide to deliver the best cloud technology and support. Our years of experience mean that our colleagues and partners understand how to serve our customers and communities through the good, and more challenging times. We are here to help, with practical advice, solutions, expertise and insight.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUCWGUPGGBU
Date   Source Headline
14th Feb 20233:59 pmRNSDirector/PDMR Shareholding
13th Feb 20236:16 pmRNSPublication of Final Terms
9th Feb 20239:32 amRNSDirector/PDMR Shareholding
7th Feb 20239:46 amRNSDirector/PDMR Shareholding
3rd Feb 202312:14 pmRNSDirector Declaration
2nd Feb 20233:31 pmRNSResult of AGM
2nd Feb 20239:57 amRNSDirector Declaration
31st Jan 20233:35 pmRNSSage: Publication of Base Prospectus
31st Jan 20233:00 pmRNSTotal Voting Rights
23rd Jan 20234:58 pmRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update for the 3 months ended 31 Dec 2022
30th Dec 202211:15 amRNSTotal Voting Rights
15th Dec 202211:21 amRNSDirector/PDMR Shareholding
8th Dec 20225:40 pmRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSUpdate on financial reporting
7th Dec 20226:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:12 amRNSNotice of AGM
6th Dec 20226:13 pmRNSDirector/PDMR Shareholding
6th Dec 20225:23 pmRNSDirector/PDMR Shareholding
6th Dec 202210:25 amRNSBlock listing Interim Review
1st Dec 202211:03 amRNSAnnual Financial Report
30th Nov 20222:00 pmRNSTotal Voting Rights
24th Nov 202210:00 amRNSNon-executive Director Appointment
18th Nov 20229:13 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSResults for the year ended 30 September 2022
15th Nov 20227:00 amRNSNon-executive Director Appointment
31st Oct 20223:00 pmRNSTotal Voting Rights
30th Sep 202211:45 amRNSTotal Voting Rights
20th Sep 20227:00 amRNSInvestor and Analyst Event
31st Aug 20223:44 pmRNSTotal Voting Rights
30th Aug 20225:10 pmRNSSage completes Lockstep acquisition
24th Aug 20223:37 pmRNSDirector/PDMR Shareholding
18th Aug 202210:19 amRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSSage to acquire Lockstep
2nd Aug 20227:00 amRNSTrading update for nine months ended 30 June 2022
29th Jul 20224:04 pmRNSTotal Voting Rights
22nd Jul 20229:02 amRNSDirectorate Change
30th Jun 20224:10 pmRNSTotal Voting Rights
24th Jun 20224:34 pmRNSDirector/PDMR Shareholding
16th Jun 20223:38 pmRNSDirector/PDMR Shareholding
8th Jun 20224:48 pmRNSDirector/PDMR Shareholding
8th Jun 20229:00 amRNSDirector Declaration
7th Jun 20222:53 pmRNSDirector/PDMR Shareholding
6th Jun 20222:00 pmRNSBlock listing Interim Review
31st May 20225:09 pmRNSTotal Voting Rights
25th May 20225:24 pmRNSDirector/PDMR Shareholding
19th May 20225:36 pmRNSDirector/PDMR Shareholding
19th May 20225:20 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSResults for the 6 months to 31 March 22 unaudited
29th Apr 20224:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.